File Download
  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Peri-operative management of anti-platelet agents and anti-thrombotic agents in geriatric patients undergoing semi-urgent hip fracture surgery

TitlePeri-operative management of anti-platelet agents and anti-thrombotic agents in geriatric patients undergoing semi-urgent hip fracture surgery
Authors
KeywordsOsteoporosis
Issue Date2010
PublisherSpringer U K. The Journal's web site is located at http://www.springer.com/medicine/orthopedics/journal/198
Citation
Osteoporosis International, 2010, v. 21 SUPPL. 4, p. S573-S577 How to Cite?
AbstractHip fractures are common events in the geriatric population and are often associated with significant morbidity and mortality. Over the coming decades, the size of the greying population is forecast to increase and hence, the annual incidence of hip fracture is expected to rise substantially. Several studies have shown that hip fracture surgery performed within 24 to 48 h of hospitalisation significantly reduces mortality. Medical specialists including cardiologists are often involved in the care of these geriatric patients as most of them have comorbid conditions that must be managed concomitantly with their fracture. Cardiovascular and thromboembolic complications are among some of the commonest adverse events that could be experienced by these elderly patients during hospitalisation. We review in this article the current recommendations and controversies on the peri-operative management of anti-platelet agents and anti-thrombotic agents in geriatric patients undergoing semi-urgent hip fracture surgery. © 2010 The Author(s).
Persistent Identifierhttp://hdl.handle.net/10722/135288
ISSN
2015 Impact Factor: 3.445
2015 SCImago Journal Rankings: 1.460
PubMed Central ID
ISI Accession Number ID
Funding AgencyGrant Number
Synthes
Funding Information:

Dr. Leung is the speaker for Synthes and has received research support from Synthes. None of the other authors has a real or perceived conflict of interest or a disclosure of any personal or financial support.

References

 

DC FieldValueLanguage
dc.contributor.authorHo, HHen_HK
dc.contributor.authorLau, TWen_HK
dc.contributor.authorLeung, Fen_HK
dc.contributor.authorTse, HFen_HK
dc.contributor.authorSiu, CWen_HK
dc.date.accessioned2011-07-27T01:31:28Z-
dc.date.available2011-07-27T01:31:28Z-
dc.date.issued2010en_HK
dc.identifier.citationOsteoporosis International, 2010, v. 21 SUPPL. 4, p. S573-S577en_HK
dc.identifier.issn0937-941Xen_HK
dc.identifier.urihttp://hdl.handle.net/10722/135288-
dc.description.abstractHip fractures are common events in the geriatric population and are often associated with significant morbidity and mortality. Over the coming decades, the size of the greying population is forecast to increase and hence, the annual incidence of hip fracture is expected to rise substantially. Several studies have shown that hip fracture surgery performed within 24 to 48 h of hospitalisation significantly reduces mortality. Medical specialists including cardiologists are often involved in the care of these geriatric patients as most of them have comorbid conditions that must be managed concomitantly with their fracture. Cardiovascular and thromboembolic complications are among some of the commonest adverse events that could be experienced by these elderly patients during hospitalisation. We review in this article the current recommendations and controversies on the peri-operative management of anti-platelet agents and anti-thrombotic agents in geriatric patients undergoing semi-urgent hip fracture surgery. © 2010 The Author(s).en_HK
dc.languageengen_US
dc.publisherSpringer U K. The Journal's web site is located at http://www.springer.com/medicine/orthopedics/journal/198en_HK
dc.relation.ispartofOsteoporosis Internationalen_HK
dc.rightsThe Author(s)-
dc.rightsCreative Commons: Attribution 3.0 Hong Kong Licenseen_US
dc.subjectOsteoporosisen_HK
dc.subject.meshFibrinolytic Agents - contraindications - therapeutic use-
dc.subject.meshHip Fractures - surgery-
dc.subject.meshOsteoporotic Fractures - surgery-
dc.subject.meshPerioperative Care - methods-
dc.subject.meshPlatelet Aggregation Inhibitors - contraindications - therapeutic use-
dc.titlePeri-operative management of anti-platelet agents and anti-thrombotic agents in geriatric patients undergoing semi-urgent hip fracture surgeryen_HK
dc.typeArticleen_HK
dc.identifier.openurlhttp://library.hku.hk:4550/resserv?sid=HKU:IR&issn=0937-941X&volume=21&issue=Suppl 4&spage=S573&epage=S577&date=2010&atitle=Peri-operative+management+of+anti-platelet+agents+and+anti-thrombotic+agents+in+geriatric+patients+undergoing+semi-urgent+hip+fracture+surgery-
dc.identifier.emailLeung, F:klleunga@hku.hken_HK
dc.identifier.emailTse, HF:hftse@hkucc.hku.hken_HK
dc.identifier.emailSiu, CW:cwdsiu@hkucc.hku.hken_HK
dc.identifier.authorityLeung, F=rp00297en_HK
dc.identifier.authorityTse, HF=rp00428en_HK
dc.identifier.authoritySiu, CW=rp00534en_HK
dc.description.naturepublished_or_final_version-
dc.identifier.doi10.1007/s00198-010-1416-xen_HK
dc.identifier.pmid21057996-
dc.identifier.pmcidPMC2974916-
dc.identifier.scopuseid_2-s2.0-78449309379en_HK
dc.identifier.hkuros185975en_US
dc.relation.referenceshttp://www.scopus.com/mlt/select.url?eid=2-s2.0-78449309379&selection=ref&src=s&origin=recordpageen_HK
dc.identifier.volume21en_HK
dc.identifier.issueSUPPL. 4en_HK
dc.identifier.spageS573en_HK
dc.identifier.epageS577en_HK
dc.identifier.isiWOS:000289889600007-
dc.publisher.placeUnited Kingdomen_HK
dc.description.otherSpringer Open Choice, 31 May 2011-
dc.identifier.scopusauthoridHo, HH=35209997400en_HK
dc.identifier.scopusauthoridLau, TW=42761610400en_HK
dc.identifier.scopusauthoridLeung, F=7103078631en_HK
dc.identifier.scopusauthoridTse, HF=7006070805en_HK
dc.identifier.scopusauthoridSiu, CW=7006550690en_HK

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats